These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 16289744)

  • 1. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism.
    Moon YJ; Wang X; Morris ME
    Toxicol In Vitro; 2006 Mar; 20(2):187-210. PubMed ID: 16289744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer.
    Srinivasan P; Suchalatha S; Babu PV; Devi RS; Narayan S; Sabitha KE; Shyamala Devi CS
    Chem Biol Interact; 2008 Apr; 172(3):224-34. PubMed ID: 18336807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of the flavonoids on cytochrome P-450 CYP1, 2E1, 3A4 and 19].
    Zheng J; Zhou HH
    Yao Xue Xue Bao; 2007 Jan; 42(1):8-12. PubMed ID: 17520800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-metabolizing enzymes: mechanisms and functions.
    Sheweita SA
    Curr Drug Metab; 2000 Sep; 1(2):107-32. PubMed ID: 11465078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat.
    Breinholt V; Lauridsen ST; Dragsted LO
    Xenobiotica; 1999 Dec; 29(12):1227-40. PubMed ID: 10647909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
    Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
    Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450.
    Hodek P; Trefil P; Stiborová M
    Chem Biol Interact; 2002 Jan; 139(1):1-21. PubMed ID: 11803026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of hepatic drug-metabolizing enzymes in rats treated with alkyl sulfides.
    Siess MH; Le Bon AM; Canivenc-Lavier MC; Suschetet M
    Cancer Lett; 1997 Dec; 120(2):195-201. PubMed ID: 9461037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of xenobiotic metabolizing enzymes by vanadium during diethylnitrosamine-induced hepatocarcinogenesis in Sprague-Dawley rats.
    Chakraborty A; Selvaraj S
    Neoplasma; 2000; 47(2):81-9. PubMed ID: 10985472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver.
    Canivenc-Lavier MC; Vernevaut MF; Totis M; Siess MH; Magdalou J; Suschetet M
    Toxicology; 1996 Nov; 114(1):19-27. PubMed ID: 8931757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of phase I and phase II xenobiotic-metabolizing enzymes by selenium-enriched garlic in rats.
    Ip C; Lisk DJ
    Nutr Cancer; 1997; 28(2):184-8. PubMed ID: 9290126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics.
    Schrenk D
    Biochem Pharmacol; 1998 Apr; 55(8):1155-62. PubMed ID: 9719469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas.
    Standop J; Ulrich AB; Schneider MB; Büchler MW; Pour PM
    Pancreatology; 2002; 2(6):510-8. PubMed ID: 12435863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multienzyme-mediated stable and transient multidrug resistance and collateral sensitivity induced by xenobiotics.
    Rekha GK; Sladek NE
    Cancer Chemother Pharmacol; 1997; 40(3):215-24. PubMed ID: 9219504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of phase II enzymes by genistein and daidzein in male and female Swiss Webster mice.
    Froyen EB; Reeves JL; Mitchell AE; Steinberg FM
    J Med Food; 2009 Dec; 12(6):1227-37. PubMed ID: 20041775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcript profiling of enzymes involved in detoxification of xenobiotics and reactive oxygen in human normal and simian virus 40 T antigen-immortalized oral keratinocytes.
    Vondracek M; Weaver DA; Sarang Z; Hedberg JJ; Willey JC; Wärngård L; Grafström RC
    Int J Cancer; 2002 Jun; 99(6):776-82. PubMed ID: 12115477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dietary constituents with chemopreventive potential on adduct formation of a low dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes.
    Dingley KH; Ubick EA; Chiarappa-Zucca ML; Nowell S; Abel S; Ebeler SE; Mitchell AE; Burns SA; Steinberg FM; Clifford AJ
    Nutr Cancer; 2003; 46(2):212-21. PubMed ID: 14690798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
    Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
    Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of baicalein and wogonin on drug-metabolizing enzymes in C57BL/6J mice.
    Ueng YF; Shyu CC; Lin YL; Park SS; Liao JF; Chen CF
    Life Sci; 2000 Sep; 67(18):2189-200. PubMed ID: 11045600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.